Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter van Wijngaarden

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Clinical & Experimental Ophthalmology|July 9, 2020
Metabolic pathways in context: mTOR signalling in the retina and optic nerve - A reviewAnthony Yao, Peter van Wijngaarden
Clinical & Experimental Ophthalmology|November 29, 2018
The eye in AI: artificial intelligence in ophthalmologyStuart Keel, Peter van Wijngaarden
Clinical & Experimental Ophthalmology|October 6, 2018
More than meets the eye: an association between diet soft drink consumption and proliferative diabetic retinopathyPeter van Wijngaarden, Stuart Keel
Clinical & Experimental Optometry|July 19, 2008
Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practicePeter van Wijngaarden, Salmaan H Qureshi
Clinical & Experimental Ophthalmology|January 29, 2016
Glaucoma neurorecovery - a sugar-coated road to retinal ganglion cell recoveryJonathan G Crowston, Peter van Wijngaarden
Development (Cambridge, England)|May 30, 2013
Ageing stem and progenitor cells: implications for rejuvenation of the central nervous systemPeter van Wijngaarden, Robin J M Franklin
Eye (London, England)|May 22, 2024
Hyperspectral retinal imaging biomarkers of ocular and systemic diseasesAbera Saeed, Xavier Hadoux, Peter van Wijngaarden
Survey of Ophthalmology|January 31, 2026
Foundation models for ophthalmic imagingKayvan Gharbi, Peter van Wijngaarden, Xavier Hadoux
The Medical Journal of Australia|February 14, 2021
Ophthalmology and the emergence of artificial intelligenceJane Scheetz, Mingguang He, Peter van Wijngaarden
JAMA Ophthalmology|February 8, 2019
The Case for Extended Screening Intervals for People With Diabetes and No or Minimal Retinopathy at BaselinePeter van Wijngaarden, Stuart Keel, Peter H Scanlon
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Clinical & Experimental Ophthalmology|July 9, 2020
Metabolic pathways in context: mTOR signalling in the retina and optic nerve - A reviewAnthony Yao, Peter van Wijngaarden
Clinical & Experimental Ophthalmology|November 29, 2018
The eye in AI: artificial intelligence in ophthalmologyStuart Keel, Peter van Wijngaarden
Clinical & Experimental Ophthalmology|October 6, 2018
More than meets the eye: an association between diet soft drink consumption and proliferative diabetic retinopathyPeter van Wijngaarden, Stuart Keel
Clinical & Experimental Optometry|July 19, 2008
Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practicePeter van Wijngaarden, Salmaan H Qureshi
Clinical & Experimental Ophthalmology|January 29, 2016
Glaucoma neurorecovery - a sugar-coated road to retinal ganglion cell recoveryJonathan G Crowston, Peter van Wijngaarden
Development (Cambridge, England)|May 30, 2013
Ageing stem and progenitor cells: implications for rejuvenation of the central nervous systemPeter van Wijngaarden, Robin J M Franklin
Eye (London, England)|May 22, 2024
Hyperspectral retinal imaging biomarkers of ocular and systemic diseasesAbera Saeed, Xavier Hadoux, Peter van Wijngaarden
Survey of Ophthalmology|January 31, 2026
Foundation models for ophthalmic imagingKayvan Gharbi, Peter van Wijngaarden, Xavier Hadoux
The Medical Journal of Australia|February 14, 2021
Ophthalmology and the emergence of artificial intelligenceJane Scheetz, Mingguang He, Peter van Wijngaarden
JAMA Ophthalmology|February 8, 2019
The Case for Extended Screening Intervals for People With Diabetes and No or Minimal Retinopathy at BaselinePeter van Wijngaarden, Stuart Keel, Peter H Scanlon
Pageof 15